Risks of in utero exposure to valproate

doi:10.1001/jama.2013.4001

Editorial

. 2013 Apr 24;309(16):1730-1.

doi: 10.1001/jama.2013.4001.

Risks of in utero exposure to valproate

Kimford J Meador, David W Loring

PMID: 23613078
PMCID: PMC3685023
DOI: 10.1001/jama.2013.4001

Editorial

Risks of in utero exposure to valproate

Kimford J Meador et al. JAMA. 2013.

. 2013 Apr 24;309(16):1730-1.

doi: 10.1001/jama.2013.4001.

Authors

Kimford J Meador, David W Loring

PMID: 23613078
PMCID: PMC3685023
DOI: 10.1001/jama.2013.4001

No abstract available

PubMed Disclaimer

Comment on

Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Christensen J, et al. JAMA. 2013 Apr 24;309(16):1696-703. doi: 10.1001/jama.2013.2270. JAMA. 2013. PMID: 23613074 Free PMC article.

Cited by

Gestational Valproate Exposure Induces Tissue-Specific Transcriptomic Changes in the Neonatal Brain and Choroid Plexus in a Rat Model of Epilepsy, GAERS.
Qiu F, Huang Y, Dziegielewska KM, Habgood MD, Saunders NR. Qiu F, et al. Eur J Neurosci. 2025 May;61(10):e70139. doi: 10.1111/ejn.70139. Eur J Neurosci. 2025. PMID: 40369861 Free PMC article.
Degraded auditory processing in a rat model of autism limits the speech representation in non-primary auditory cortex.
Engineer CT, Centanni TM, Im KW, Borland MS, Moreno NA, Carraway RS, Wilson LG, Kilgard MP. Engineer CT, et al. Dev Neurobiol. 2014 Oct;74(10):972-86. doi: 10.1002/dneu.22175. Epub 2014 Apr 4. Dev Neurobiol. 2014. PMID: 24639033 Free PMC article.
Black-Box Warnings of Antiseizure Medications: What is Inside the Box?
Wahab A, Iqbal A. Wahab A, et al. Pharmaceut Med. 2023 May;37(3):233-250. doi: 10.1007/s40290-023-00475-x. Epub 2023 Apr 29. Pharmaceut Med. 2023. PMID: 37119452 Review.
Women with epilepsy planning pregnancy: we can improve outcomes by improving care.
French JA. French JA. Epilepsy Curr. 2013 Sep;13(5):209-10. doi: 10.5698/1535-7597-13.5.209. Epilepsy Curr. 2013. PMID: 24348106 Free PMC article. No abstract available.
Modified hemispherectomy for infantile hemiparesis and epilepsy.
Li YH, Li DS, Wang MQ, Zhao K, Gao BL. Li YH, et al. Transl Neurosci. 2020 Oct 20;11(1):380-390. doi: 10.1515/tnsci-2020-0145. eCollection 2020. Transl Neurosci. 2020. PMID: 33335778 Free PMC article.

See all "Cited by" articles

References

1. Adedinsewo DA. Trends in Valproate Prescriptions for Non-Epilepsy Indications among Women Aged 15-44 Years U.S. 1996-2007 [A Population-Based Study] [master's thesis] Emory University; Atlanta, GA: 2012. [March 15, 2013]. https://etd.library.emory.edu/view/record/pid/emory:bqmst.
1. Harden CL, Meador KJ, Pennell PB, et al. American Academy of Neurology. American Epilepsy Society Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):133–141. - PMC - PubMed
1. Meador KJ, Baker GA, Browning N, et al. NEAD Study Group Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360(16):1597–1605. - PMC - PubMed
1. US Food and Drug Administration (FDA) [March 15, 2013];FDA Drug Safety Communication: Children Born to Mothers Who Took Valproate Products While Pregnant May Have Impaired Cognitive Development. FDA website. http://www.fda.gov/Drugs/DrugSafety/ucm261543.htm. June 30, 2011.
1. Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37(7):489–497. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

[1] Adedinsewo DA. Trends in Valproate Prescriptions for Non-Epilepsy Indications among Women Aged 15-44 Years U.S. 1996-2007 [A Population-Based Study] [master's thesis] Emory University; Atlanta, GA: 2012. [March 15, 2013]. https://etd.library.emory.edu/view/record/pid/emory:bqmst.

[2] Adedinsewo DA. Trends in Valproate Prescriptions for Non-Epilepsy Indications among Women Aged 15-44 Years U.S. 1996-2007 [A Population-Based Study] [master's thesis] Emory University; Atlanta, GA: 2012. [March 15, 2013]. https://etd.library.emory.edu/view/record/pid/emory:bqmst.

[3] Harden CL, Meador KJ, Pennell PB, et al. American Academy of Neurology. American Epilepsy Society Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):133–141. - PMC - PubMed

[4] Harden CL, Meador KJ, Pennell PB, et al. American Academy of Neurology. American Epilepsy Society Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):133–141. - PMC - PubMed

[5] Meador KJ, Baker GA, Browning N, et al. NEAD Study Group Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360(16):1597–1605. - PMC - PubMed

[6] Meador KJ, Baker GA, Browning N, et al. NEAD Study Group Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360(16):1597–1605. - PMC - PubMed

[7] US Food and Drug Administration (FDA) [March 15, 2013];FDA Drug Safety Communication: Children Born to Mothers Who Took Valproate Products While Pregnant May Have Impaired Cognitive Development. FDA website. http://www.fda.gov/Drugs/DrugSafety/ucm261543.htm. June 30, 2011.

[8] US Food and Drug Administration (FDA) [March 15, 2013];FDA Drug Safety Communication: Children Born to Mothers Who Took Valproate Products While Pregnant May Have Impaired Cognitive Development. FDA website. http://www.fda.gov/Drugs/DrugSafety/ucm261543.htm. June 30, 2011.

[9] Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37(7):489–497. - PMC - PubMed

[10] Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37(7):489–497. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Risks of in utero exposure to valproate

Risks of in utero exposure to valproate

Authors

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical